Sculptor Capital’s HOOKIPA Pharma HOOK Stock Holding History

Sculptor Capital’s Portfolio HOOK Stock Details HOOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,910	Closed	-$89K	–	1180
2022 Q1	$89K	Buy	+3,910	New	+$70.1K	﹤0.01%	968

Other funds holding HOOK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sculptor Capital's HOOK Position: Q2 2022 in Review

Sculptor Capital sold out of HOOKIPA Pharma (HOOK) in Q2 2022, closing a stake of 3,910 shares — an estimated $89K sold.

Sculptor Capital first reported a position in HOOK in Q1 2022 and held it in 1 quarter. The position peaked at $89K in Q1 2022. 58 funds tracked by Wall St. Rank hold HOOK as of Q2 2022.

Sculptor Capital reported no remaining HOOKIPA Pharma position as of Q2 2022 after selling out during the quarter.
Sculptor Capital sold 3,910 HOOKIPA Pharma shares in Q2 2022, an estimated $89K.
Sculptor Capital first reported a position in HOOKIPA Pharma in Q1 2022 and held it in 1 quarter.
Sculptor Capital's HOOKIPA Pharma position peaked at $89K in Q1 2022.
58 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q2 2022.

Based on Sculptor Capital's 13F filing for Q2 2022, filed 12 Aug 2022.